Dihydroactinidiolide

CAS No. 17092-92-1

Dihydroactinidiolide( —— )

Catalog No. M18118 CAS No. 17092-92-1

Dihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 40 In Stock
100MG 61 In Stock
200MG 87 In Stock
500MG 142 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydroactinidiolide
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
  • Description
    Dihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17092-92-1
  • Formula Weight
    180.24
  • Molecular Formula
    C11H16O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (554.82 mM)
  • SMILES
    CC1(CCC[C@@]2(C1=CC(=O)O2)C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shumbe L, et al. Dihydroactinidiolide, a high light-induced β-carotene derivative that can regulate gene expression and photoacclimation in Arabidopsis. Mol Plant. 2014 Jul;7(7):1248-51.
molnova catalog
related products
  • BRD4-BD1-IN-2

    BRD4-BD1-IN-2 is a selective and potent BRD4-BD1 inhibitor with an IC50 value of 2.51 μM, exhibiting 20-fold greater inhibitory activity against BRD4-BD1 compared to BRD4-BD2.

  • Y06137

    Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.

  • SRX3177

    SRX3177 is a novel and potent inhibitor of BRD4, PI3K and CDK.SRX3177 has potential anticancer activity.